AXSOME THERAPEUTICS INC COM is a security (CUSIP 05464T104) tracked across SEC portfolio filings. 456 institutional managers reported $6.3B on Form 13F as of 2026-06-30; 41 registered fund positions totaling $424.9M via N-PORT as of 2026-05-31.
Showing 15 of 456 managers by value.
| Manager | Location | Value | Shares |
|---|---|---|---|
| VANGUARD GROUP INC | Valley Forge, PA | $760.7M | 4,164,818 |
| BlackRock, Inc. | New York, NY | $661.3M | 3,912,844 |
| FMR LLC | BOSTON, MA | $264.9M | 1,566,995 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $196.6M | 1,162,981 |
| WELLINGTON MANAGEMENT GROUP LLP | BOSTON, MA | $193.6M | 1,145,306 |
| Deep Track Capital, LP | GREENWICH, CT | $185.9M | 1,100,000 |
| STATE STREET CORP | BOSTON, MA | $166.8M | 986,809 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | PHILADELPHIA, PA | $137.4M | 812,809 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Boston, MA | $124.7M | 737,578 |
| Assenagon Asset Management S.A. | SENNINGERBERG, N4 | $111.3M | 454,682 |
| ALETHEA CAPITAL MANAGEMENT, LLC | SAN DIEGO, CA | $109.7M | 649,114 |
| Pictet Asset Management Holding SA | CAROUGE, V8 | $104.4M | 426,527 |
| D. E. Shaw & Co., Inc. | New York, NY | $102.6M | 603,465 |
| BANK OF AMERICA CORP /DE/ | CHARLOTTE, NC | $101.1M | 598,091 |
| FIRST TRUST ADVISORS LP | Wheaton, IL | $97.6M | 577,479 |
Showing 15 of 41 fund positions by value.
| Fund | Registrant | Value | % of fund |
|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND | VANGUARD INDEX FUNDS | $79.8M | 9.80% |
| VANGUARD EXPLORER FUND | VANGUARD EXPLORER FUND | $75.9M | 34.87% |
| T. Rowe Price New Horizons Fund, Inc. | T. ROWE PRICE NEW HORIZONS FUND, INC. | $68.9M | 53.99% |
| VANGUARD RUSSELL 2000 INDEX FUND | VANGUARD SCOTTSDALE FUNDS | $49.9M | 28.48% |
| T. Rowe Price Health Sciences Fund, Inc. | T. ROWE PRICE HEALTH SCIENCES FUND, INC. | $27.7M | 25.43% |
| Fidelity Advisor Health Care Fund | Fidelity Advisor Series VII | $23.3M | 80.60% |
| abrdn Healthcare Investors | abrdn Healthcare Investors | $12.8M | 112.89% |
| abrdn Life Sciences Investors | abrdn Life Sciences Investors | $12.5M | 222.25% |
| Master Small Cap Index Series | Quantitative Master Series LLC | $11.4M | 23.68% |
| Optimum Small-Mid Cap Growth Fund | Optimum Fund Trust | $7.3M | 96.24% |
| ROYCE SMALL-CAP TRUST, INC. | ROYCE SMALL-CAP TRUST, INC. | $6.9M | 31.08% |
| Emerald Growth Fund | FINANCIAL INVESTORS TRUST | $5.8M | 41.52% |
| BlackRock Health Sciences Term Trust | BlackRock Health Sciences Term Trust | $4.9M | 48.02% |
| VANGUARD BALANCED INDEX FUND | VANGUARD VALLEY FORGE FUNDS | $4.2M | 0.71% |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | VANGUARD INSTITUTIONAL INDEX FUNDS | $3.6M | 1.20% |